Showing 211-220 of 345 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| ST2 Tregs in enhancing islet transplantation | Rector & Visitors of the University of Virginia | Rahul Sharma | Cures | 01-July-2025 to 30-June-2028 | $499,997.13 |
| Alternative Splicing as a Trigger for Initiation and Progression of Islet Autoimmunity | Rector & Visitors of the University of Virginia | Stephen Rich | Cures | 01-February-2026 to 31-January-2029 | $880,914.00 |
| Evaluation of a novel insulin sensitizer on glycemic control, insulin usage, and cardiovascular biomarkers in people with type 1 diabetes who use closed-loop automated insulin delivery | Rector & Visitors of the University of Virginia | William Horton | Improving Lives | 01-August-2025 to 31-July-2028 | $1,031,908.99 |
| Reducing Glycemic Variability to Improve Cardiovascular Health in Type 1 Diabetes | Rector & Visitors of the University of Virginia | William Horton | Improving Lives | 01-December-2022 to 30-June-2027 | $858,072.00 |
| Advancing Breakthroughs in Type 1 Diabetes Research with Safe and Immune Cloaked Stem Cells | Pluristyx | Benjamin Fryer | Cures | 15-November-2025 to 14-November-2027 | $704,860.20 |
| Early identification strategies to assist with prevention of eating disorders (insulin restriction) in Type 1 diabetes | Penn State College of Medicine | Heather Stuckey | Improving Lives | 01-October-2023 to 30-September-2026 | $488,976.45 |
| Moving the field forward: A landscape review of psychosocial, behavioral and mental health in Type 1 diabetes | Penn State College of Medicine | Heather Stuckey | Improving Lives | 01-October-2024 to 31-March-2026 | $71,613.88 |
| Inhibition of REDD1 Allostery as a Therapeutic for Type 1 Diabetes | Penn State College of Medicine | Michael Dennis | Improving Lives | 01-June-2024 to 31-May-2026 | $200,000.00 |
| Development of an AI-informed Bayesian decision support system for optimizing benefit in islet transplant therapy | Oregon State University | Peter Jacobs | Cures | 01-June-2025 to 31-May-2028 | $749,999.83 |
| A New Preparation of the Intact Eye for Measurements of Retinal Dysfunction in Acute Hyperglycemia and Early Diabetes | Northwestern University | Gregory Schwartz | Improving Lives | 01-October-2023 to 30-September-2026 | $406,927.40 |